Renal Replacement Therapy in Patients with Heart and Kidney Failure

1. Udani SM and Murray PT. The use of renal replacement therapy in acute decompensated heart failure. Semin Dial. 2009; 22: 173–179.10.1111/j.1525-139X.2008.00542.xSearch in Google Scholar

2. Verbrugge FH, Grieten L, Mullens W. Management of the cardiorenal syndrome in decompensated heart failure. Cardiorenal Med. 2014; 4: 176–188.10.1159/000366168Search in Google Scholar

3. Forman DE, Butler J, Wang Y, Abraham WT et al. Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure. J Am Coll Cardiol. 2004; 43: 61–67.10.1016/j.jacc.2003.07.031Search in Google Scholar

4. Kazory A. Cardiorenal syndrome: ultrafiltration therapy for heart failure–trials and tribulations. Clin J Am Soc Nephrol. 2013; 8: 1816–1828.10.2215/CJN.02910313Search in Google Scholar

5. Bart BA, Boyle A, Bank AJ, Anand I, et al. Ultrafiltration versus usual care for hospitalized patients with heart failure: the Relief for Acutely Fluid-Overloaded Patients With Decompensated Congestive Heart Failure (RAPID-CHF) trial. J Am Coll Cardiol. 2005; 46: 2043–2046.10.1016/j.jacc.2005.05.098Search in Google Scholar

6. Costanzo MR, Guglin ME, Saltzberg MT, Jessup ML, et al. UNLOAD Trial Investigators. Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure. J Am Coll Cardiol. 2007; 49: 675–683.10.1016/j.jacc.2006.07.073Search in Google Scholar

7. Marenzi G, Muratori M, Cosentino ER, Rinaldi ER, et al. Continuous ultrafiltration for congestive heart failure: the CUORE trial. J Card Fail. 2014; 20: 9–17.10.1016/j.cardfail.2013.11.004Search in Google Scholar

8. Chen HY, Chou KJ, Fang HC, Chen CL, et al. Effect of ultrafiltration versus intravenous furosemide for decompensated heart failure in cardiorenal syndrome: a systematic review with meta-analysis of randomized controlled trials. Nephron. 2015; 129(3): 189–96.10.1159/000371447Search in Google Scholar

9. Krishnamoorthy A and Felker GM. Fluid removal in acute heart failure: diuretics versus devices. Curr Op Crit Care. 2014; 20: 478–483.10.1097/MCC.0000000000000134Search in Google Scholar

10. Nakayama M. Nonuremic indication for peritoneal dialysis for refractory heart failure in cardiorenal syndrome type II: review and perspective. Perit Dial Int. 2013; 33: 8–14.10.3747/pdi.2012.00014Search in Google Scholar

11. Bertoli SV, Musetti C, Ciurlino D, Basile C, et al. Peritoneal ultrafiltration in refractory heart failure: a cohort study. Perit Dial Int. 2014; 34: 64–70.10.3747/pdi.2012.00290Search in Google Scholar

12. Courivaud C, Kazory A, Crépin T, Azar R, et al. Peritoneal dialysis reduces the number of hospitalizetion days in heart failure patients refractory to diuretics. Perit Dial Int 2014; 34: 100–108.10.3747/pdi.2012.00149Search in Google Scholar

13. Lu R, Muciño-Bermejo MJ, Ribeiro LC, Tonini E, et al. Peritoneal dialysis in patients with refractory congestive heart failure: a systematic review. Cardiorenal Med. 2015; 5: 145–156.10.1159/000380915Search in Google Scholar

14. Puttagunta H and Holt SG. Peritoneal Dialysis for Heart Failure. Perit Dial Int. 2015; 35: 645–649.10.3747/pdi.2014.00340Search in Google Scholar

15. Kazory A. Peritoneal dialysis for chronic cardiorenal syndrome: Lessons learned from ultrafiltration trials. World J Cardiol. 2015; 26: 392–396.10.4330/wjc.v7.i7.392Search in Google Scholar